urlscan.io logo urlscan.io
SecurityTrails logo

www.renaissancecapital.com Open in urlscan Pro
173.251.78.140  Public Scan

Go To Rescan Add Verdict Report
Submitted URL: https://t.co/zgTxwhdbsM?amp=1
Effective URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Submission: On June 09 via manual from SG
 Behaviour Indicators
Similar DOM Content API
Verdicts

Summary

This website contacted 24 IPs in 6 countries across 22 domains to perform 73 HTTP transactions. The main IP is 173.251.78.140, located in Nutley, United States and belongs to CABLE-NET-1, US. The main domain is www.renaissancecapital.com.
TLS certificate: Issued by SSL.com RSA SSL subCA on April 9th 2020. Valid for: 2 years.
This is the only time www.renaissancecapital.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
2 104.244.42.5 13414 (TWITTER)
1 1 18.214.66.67 14618 (AMAZON-AES)
28 173.251.78.140 6128 (CABLE-NET-1)
1 2606:4700::68... 13335 (CLOUDFLAR...)
2 2a00:1450:400... 15169 (GOOGLE)
1 2 2a00:1450:400... 15169 (GOOGLE)
1 151.101.112.157 54113 (FASTLY)
1 1 2a00:1450:400... 15169 (GOOGLE)
1 2 2a00:1450:400... 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
1 216.58.207.34 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a02:26f0:10c... 20940 (AKAMAI-ASN1)
3 46.101.154.21 14061 (DIGITALOC...)
1 2 2a05:f500:11:... 14413 (LINKEDIN)
1 1 2620:1ec:21::14 8068 (MICROSOFT...)
1 104.244.42.195 13414 (TWITTER)
1 195.181.175.49 60068 (CDN77)
1 195.181.175.51 60068 (CDN77)
2 2001:4de0:ac1... 20446 (HIGHWINDS3)
1 2a00:1450:400... 15169 (GOOGLE)
2 195.181.175.46 60068 (CDN77)
10 2a00:1450:400... 15169 (GOOGLE)
1 5 184.51.8.183 16625 (AKAMAI-AS)
1 3 99.81.9.236 16509 (AMAZON-02)
2 2a03:2880:f05... 32934 (FACEBOOK)
2 2a03:2880:f15... 32934 (FACEBOOK)
73 24
2    104.244.42.5 (United States)

ASN13414 (TWITTER, US)
t.co
1    18.214.66.67 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-18-214-66-67.compute-1.amazonaws.com
zpr.io
28    173.251.78.140 (Nutley, United States)

ASN6128 (CABLE-NET-1, US)
PTR: renaissancecapital.com
www.renaissancecapital.com
data.renaissancecapital.com
1    2606:4700::6810:85e5 (United States)

ASN13335 (CLOUDFLARENET, US)
cdnjs.cloudflare.com
2    2a00:1450:4001:809::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
www.googletagmanager.com
2    2a00:1450:4001:81b::200e (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
www.google-analytics.com
1    151.101.112.157 (Frankfurt am Main, Germany)

ASN54113 (FASTLY, US)
static.ads-twitter.com
1    2a00:1450:400c:c00::9b (Brussels, Belgium)

ASN15169 (GOOGLE, US)
stats.g.doubleclick.net
2    2a00:1450:4001:815::2004 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
www.google.com
2    2a00:1450:4001:814::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
www.google.de
1    216.58.207.34 (Mountain View, United States)

ASN15169 (GOOGLE, US)
PTR: fra16s24-in-f2.1e100.net
www.googleadservices.com
1    2a00:1450:4001:809::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
googleads.g.doubleclick.net
1    2a02:26f0:10c:382::25ea (Ascension Island)

ASN20940 (AKAMAI-ASN1, EU)
snap.licdn.com
3    46.101.154.21 (Frankfurt am Main, Germany)

ASN14061 (DIGITALOCEAN-ASN, US)
front.optimonk.com
2    2a05:f500:11:101::b93f:9005 (Ireland)

ASN14413 (LINKEDIN, US)
px.ads.linkedin.com
1    2620:1ec:21::14 (United States)

ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US)
www.linkedin.com
1    104.244.42.195 (United States)

ASN13414 (TWITTER, US)
analytics.twitter.com
1    195.181.175.49 (Frankfurt am Main, Germany)

ASN60068 (CDN77, GB)
PTR: frankfurt-47.cdn77.com
cdn-content.optimonk.com
1    195.181.175.51 (Frankfurt am Main, Germany)

ASN60068 (CDN77, GB)
PTR: frankfurt-50.cdn77.com
cdn-static.optimonk.com
2    2001:4de0:ac19::1:b:2a (Netherlands)

ASN20446 (HIGHWINDS3, US)
maxcdn.bootstrapcdn.com
1    2a00:1450:4001:801::200a (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
fonts.googleapis.com
2    195.181.175.46 (Frankfurt am Main, Germany)

ASN60068 (CDN77, GB)
PTR: frankfurt-44.cdn77.com
editor-upload-cdn.optimonk.com
10    2a00:1450:4001:825::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
fonts.gstatic.com
5    184.51.8.183 (United States)

ASN16625 (AKAMAI-AS, US)
s.adroll.com
3    99.81.9.236 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-99-81-9-236.eu-west-1.compute.amazonaws.com
d.adroll.mgr.consensu.org
d.adroll.com
2    2a03:2880:f058:f:face:b00c:0:3 (Ireland)

ASN32934 (FACEBOOK, US)
connect.facebook.net
2    2a03:2880:f158:82:face:b00c:0:25de (Ireland)

ASN32934 (FACEBOOK, US)
www.facebook.com
Domain Requested by
27 www.renaissancecapital.com t.co
www.renaissancecapital.com
10 fonts.gstatic.com www.renaissancecapital.com
5 s.adroll.com 1 redirects www.renaissancecapital.com
s.adroll.com
3 front.optimonk.com www.renaissancecapital.com
front.optimonk.com
t.co
2 www.facebook.com
2 connect.facebook.net t.co
connect.facebook.net
2 d.adroll.com
2 editor-upload-cdn.optimonk.com www.renaissancecapital.com
2 maxcdn.bootstrapcdn.com t.co
www.renaissancecapital.com
2 px.ads.linkedin.com 1 redirects www.renaissancecapital.com
2 www.google.de www.renaissancecapital.com
2 www.google.com 1 redirects www.renaissancecapital.com
2 www.google-analytics.com 1 redirects www.googletagmanager.com
2 www.googletagmanager.com www.renaissancecapital.com
www.googletagmanager.com
2 t.co www.renaissancecapital.com
1 d.adroll.mgr.consensu.org 1 redirects
1 fonts.googleapis.com t.co
1 cdn-static.optimonk.com t.co
1 cdn-content.optimonk.com t.co
1 data.renaissancecapital.com www.renaissancecapital.com
1 analytics.twitter.com static.ads-twitter.com
1 www.linkedin.com 1 redirects
1 snap.licdn.com www.renaissancecapital.com
1 googleads.g.doubleclick.net www.googleadservices.com
1 www.googleadservices.com www.googletagmanager.com
1 stats.g.doubleclick.net 1 redirects
1 static.ads-twitter.com t.co
1 cdnjs.cloudflare.com www.renaissancecapital.com
1 zpr.io 1 redirects
73 29
Subject Issuer Validity Valid
t.co
DigiCert SHA2 High Assurance Server CA		 2020-03-05 -
2021-03-02		 a year crt.sh
*.renaissancecapital.com
SSL.com RSA SSL subCA		 2020-04-09 -
2022-06-06		 2 years crt.sh
cloudflare.com
CloudFlare Inc ECC CA-2		 2020-01-07 -
2020-10-09		 9 months crt.sh
*.google-analytics.com
GTS CA 1O1		 2020-05-20 -
2020-08-12		 3 months crt.sh
ads-twitter.com
DigiCert SHA2 High Assurance Server CA		 2019-08-14 -
2020-08-18		 a year crt.sh
www.google.de
GTS CA 1O1		 2020-05-20 -
2020-08-12		 3 months crt.sh
www.googleadservices.com
GTS CA 1O1		 2020-05-20 -
2020-08-12		 3 months crt.sh
*.g.doubleclick.net
GTS CA 1O1		 2020-05-20 -
2020-08-12		 3 months crt.sh
www.google.com
GTS CA 1O1		 2020-05-20 -
2020-08-12		 3 months crt.sh
*.licdn.com
DigiCert SHA2 Secure Server CA		 2019-04-01 -
2021-05-07		 2 years crt.sh
*.optimonk.com
AlphaSSL CA - SHA256 - G2		 2020-04-25 -
2021-04-26		 a year crt.sh
px.ads.linkedin.com
DigiCert SHA2 Secure Server CA		 2020-03-04 -
2020-09-04		 6 months crt.sh
*.twitter.com
DigiCert SHA2 High Assurance Server CA		 2020-03-05 -
2021-03-02		 a year crt.sh
1826902134.rsc.cdn77.org
Let's Encrypt Authority X3		 2020-04-21 -
2020-07-20		 3 months crt.sh
*.bootstrapcdn.com
Sectigo RSA Domain Validation Secure Server CA		 2019-09-14 -
2020-10-13		 a year crt.sh
upload.video.google.com
GTS CA 1O1		 2020-05-20 -
2020-08-12		 3 months crt.sh
1316577893.rsc.cdn77.org
Let's Encrypt Authority X3		 2020-06-08 -
2020-09-06		 3 months crt.sh
*.gstatic.com
GTS CA 1O1		 2020-05-20 -
2020-08-12		 3 months crt.sh
*.adroll.com
DigiCert SHA2 Secure Server CA		 2020-01-29 -
2021-04-29		 a year crt.sh
adroll.mgr.consensu.org
Amazon		 2019-11-06 -
2020-12-06		 a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA		 2020-05-14 -
2020-08-05		 3 months crt.sh

This page contains 1 frames:

Primary Page: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Frame ID: 26997496034CC7B1C758A136A4CF7975
Requests: 73 HTTP requests in this frame

Screenshot
Live screenshot
Full Image

Page URL History Show full URLs

  1. https://t.co/zgTxwhdbsM?amp=1 Page URL
  2. http://zpr.io/tQjiA HTTP 302
    https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$21... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • script /\/\/connect\.facebook\.net\/[^/]*\/[a-z]*\.js/i
Overall confidence: 100%
Detected patterns
  • script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i
Overall confidence: 100%
Detected patterns
  • html /<!-- (?:End )?Google Tag Manager -->/i

Page Statistics

73
Requests

100 %
HTTPS

56 %
IPv6

22
Domains

29
Subdomains

24
IPs

6
Countries

1454 kB
Transfer

3496 kB
Size

0
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. https://t.co/zgTxwhdbsM?amp=1 Page URL
  2. http://zpr.io/tQjiA HTTP 302
    https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 19
  • https://www.google-analytics.com/r/collect?v=1&_v=j82&a=989330262&t=pageview&_s=1&dl=https%3A%2F%2Fwww.renaissancecapital.com%2FIPO-Center%2FNews%2F68733%2FPreclinical-vaccine-biotech-Vaxcyte-sets-terms-for-%24210-million-IPO&dr=https%3A%2F%2Ft.co%2FzgTxwhdbsM%3Famp%3D1&ul=en-us&de=UTF-8&dt=Preclinical%20vaccine%20biotech%20Vaxcyte%20sets%20terms%20for%20%24210%20million%20IPO%20-%20Renaissance%20Capital&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=YEBAAAAB~&jid=1277299689&gjid=1431245895&cid=420277392.1591730710&tid=UA-49249493-1&_gid=149541781.1591730710&_r=1&gtm=2wg5r0NQRD4R&z=1819033172 HTTP 302
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-49249493-1&cid=420277392.1591730710&jid=1277299689&_gid=149541781.1591730710&gjid=1431245895&_v=j82&z=1819033172 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-49249493-1&cid=420277392.1591730710&jid=1277299689&_v=j82&z=1819033172 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-49249493-1&cid=420277392.1591730710&jid=1277299689&_v=j82&z=1819033172&slf_rd=1&random=3388323074
Request Chain 38
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=113542&url=https%3A%2F%2Fwww.renaissancecapital.com%2FIPO-Center%2FNews%2F68733%2FPreclinical-vaccine-biotech-Vaxcyte-sets-terms-for-%24210-million-IPO&time=1591730710578 HTTP 302
  • https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D113542%26url%3Dhttps%253A%252F%252Fwww.renaissancecapital.com%252FIPO-Center%252FNews%252F68733%252FPreclinical-vaccine-biotech-Vaxcyte-sets-terms-for-%2524210-million-IPO%26time%3D1591730710578%26liSync%3Dtrue HTTP 302
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=113542&url=https%3A%2F%2Fwww.renaissancecapital.com%2FIPO-Center%2FNews%2F68733%2FPreclinical-vaccine-biotech-Vaxcyte-sets-terms-for-%24210-million-IPO&time=1591730710578&liSync=true
Request Chain 62
  • https://s.adroll.com/j/exp/CQCUUD3XQNCLZLODBFVNZR/index.js HTTP 302
  • https://s.adroll.com/j/exp/index.js
Request Chain 64
  • https://d.adroll.mgr.consensu.org/consent/iabcheck/CQCUUD3XQNCLZLODBFVNZR?_s=1674f602e054294b4460063715d7ed6e&_b=2 HTTP 302
  • https://d.adroll.com/consent/check/CQCUUD3XQNCLZLODBFVNZR/?_s=1674f602e054294b4460063715d7ed6e&_b=2

73 HTTP transactions

Resource
Path		 Size
x-fer		 Type
MIME-Type
zgTxwhdbsM
t.co/ 		251 B
550 B 		Document
General
Check archive.org
Download Go to
Full URL
https://t.co/zgTxwhdbsM?amp=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.42.5 , United States, ASN13414 (TWITTER, US),
Reverse DNS
Software
tsa_o /
Resource Hash
334df7d0cb255d1cc7f4b2b881248ffe7af94a485ca1e56bbb71367e18262309
Security Headers
Name Value
Content-Security-Policy referrer always;
Strict-Transport-Security max-age=0
X-Xss-Protection 0

Request headers

:method
GET
:authority
t.co
:scheme
https
:path
/zgTxwhdbsM?amp=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
none
sec-fetch-mode
navigate
sec-fetch-user
?1
sec-fetch-dest
document
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status
200
cache-control
private,max-age=300
content-encoding
gzip
content-length
189
content-security-policy
referrer always;
content-type
text/html; charset=utf-8
date
Tue, 09 Jun 2020 19:25:08 GMT
expires
Tue, 09 Jun 2020 19:30:08 GMT
referrer-policy
unsafe-url
server
tsa_o
set-cookie
muc=2dcd8278-663a-421c-ac42-6a0fc1c92632; Max-Age=63072000; Expires=Thu, 9 Jun 2022 19:25:08 GMT; Domain=t.co; Secure; SameSite=None
strict-transport-security
max-age=0
vary
Origin
x-connection-hash
011a99359d92cea1926a06a1bc3d37f1
x-response-time
127
x-xss-protection
0
Primary Request Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
www.renaissancecapital.com/IPO-Center/News/68733/
Redirect Chain
  • http://zpr.io/tQjiA
  • https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
28 KB
8 KB 		Document
General
Check archive.org
Download Go to
Full URL
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Requested by
Host: t.co
URL: https://t.co/zgTxwhdbsM?amp=1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
e8d05d621af2b34b7b9bd4af7b208c5f557fb8f2fe5c78f51955278e1f28b02b

Request headers

Host
www.renaissancecapital.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
document
Referer
https://t.co/zgTxwhdbsM?amp=1
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://t.co/zgTxwhdbsM?amp=1

Response headers

Cache-Control
private
Content-Type
text/html; charset=utf-8
Content-Encoding
gzip
Vary
Accept-Encoding
Server
Microsoft-IIS/8.5
X-AspNetMvc-Version
5.2
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Date
Tue, 09 Jun 2020 19:25:07 GMT
Content-Length
7410

Redirect headers

Connection
keep-alive
Server
gunicorn/19.6.0
Date
Tue, 09 Jun 2020 19:25:09 GMT
Content-Type
text/html; charset=utf-8
Content-Length
455
Location
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Via
1.1 vegur
css
www.renaissancecapital.com/Content/ 		299 KB
74 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.renaissancecapital.com/Content/css?v=IyI8GkXJ6TtgSf6O5nYzgtx_HMAHAJOZcRCV3GxURNY1
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
1c2ef9100681d8845913ff58cd99b080cfc9cb2fa820a753efce42456aaf4e1e

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Content-Encoding
gzip
Last-Modified
Tue, 09 Jun 2020 19:25:08 GMT
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
User-Agent,Accept-Encoding
Content-Type
text/css; charset=utf-8
Cache-Control
public
Transfer-Encoding
chunked
Expires
Wed, 09 Jun 2021 19:25:08 GMT
logo-header-white.png
www.renaissancecapital.com/images/ 		35 KB
36 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.renaissancecapital.com/images/logo-header-white.png
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
989a3869392d7cda4b3a9b7430e20f472a0d88a893ba0d9d8fff2ad1dfa6d93a

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Last-Modified
Fri, 09 Feb 2018 16:46:17 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"bfea881c5a1d31:0"
Content-Type
image/png
Accept-Ranges
bytes
Content-Length
36131
logo-header-blue.png
www.renaissancecapital.com/images/ 		19 KB
19 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.renaissancecapital.com/images/logo-header-blue.png
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
736f2ad2694aa5743c7f6fae4d0eeadc2ddb18fb7a7b129beec2de1928693860

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Last-Modified
Fri, 09 Feb 2018 16:46:15 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"5afbe27fc5a1d31:0"
Content-Type
image/png
Accept-Ranges
bytes
Content-Length
19561
ipoCenter-css
www.renaissancecapital.com/Content/ 		9 KB
3 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.renaissancecapital.com/Content/ipoCenter-css?v=424DsidFEHXkLY3bjaizFd6vKmzkITvnHNPIijGPocY1
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
67410dd3069b8ea8370680cc825649ab8b939599d95a042e4d7b4a074e59625a

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Content-Encoding
gzip
Last-Modified
Tue, 09 Jun 2020 19:25:08 GMT
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
User-Agent,Accept-Encoding
Content-Type
text/css; charset=utf-8
Cache-Control
public
Content-Length
2720
Expires
Wed, 09 Jun 2021 19:25:08 GMT
article-css
www.renaissancecapital.com/Content/ 		7 KB
2 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.renaissancecapital.com/Content/article-css?v=2laKB47IaOIrtn4uIXOShqqPLvU3Gg8deHp-TZXidoc1
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
09946d3f5f41bbaacd87092c00bcccf57f360a582261b83bbf8c6b093fd1c68c

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Content-Encoding
gzip
Last-Modified
Tue, 09 Jun 2020 19:25:08 GMT
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
User-Agent,Accept-Encoding
Content-Type
text/css; charset=utf-8
Cache-Control
public
Content-Length
1328
Expires
Wed, 09 Jun 2021 19:25:08 GMT
IPO-Pro-Banner-Master-Cal.png
www.renaissancecapital.com/images/content/ 		66 KB
67 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.renaissancecapital.com/images/content/IPO-Pro-Banner-Master-Cal.png
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
1c3cf67a5d367117bf4ab1359704e298cc458eb6e8f103e1ce111cdad0c7d5af

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Last-Modified
Thu, 20 Sep 2018 18:13:53 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"418456b0d51d41:0"
Content-Type
image/png
Accept-Ranges
bytes
Content-Length
67945
RC_Corp_Logo_Est.%201991_White_small.png
www.renaissancecapital.com/Content/Images/Logos/ 		15 KB
16 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.renaissancecapital.com/Content/Images/Logos/RC_Corp_Logo_Est.%201991_White_small.png
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
6e59d139a8c3670f6513e25e4569aac6ac680bac1af39eb14eee07e801e17ae9

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Last-Modified
Fri, 09 Feb 2018 16:46:30 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"27f25389c5a1d31:0"
Content-Type
image/png
Accept-Ranges
bytes
Content-Length
15786
jquery
www.renaissancecapital.com/bundles/ 		85 KB
39 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.renaissancecapital.com/bundles/jquery?v=DilzeZuJxdbQsfc_JOwsWB4VFDhTPM73urYeggaKdL81
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
17b1fec86f2799119ad9051477be641fcc40e0c86a09f7c49c4d1b93ac556869

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Content-Encoding
gzip
Last-Modified
Tue, 09 Jun 2020 19:25:08 GMT
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
User-Agent,Accept-Encoding
Content-Type
text/javascript; charset=utf-8
Cache-Control
public
Content-Length
39217
Expires
Wed, 09 Jun 2021 19:25:08 GMT
bootstrap
www.renaissancecapital.com/bundles/ 		36 KB
13 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.renaissancecapital.com/bundles/bootstrap?v=lescQEuG5u4jd-GcVDBcbpUOSyTDIg0Kk9zHDX55GCw1
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
72c93f899b0c28052a481f2e4177bfc6d400c3a10f51585cfbf079e9706aa003

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Content-Encoding
gzip
Last-Modified
Tue, 09 Jun 2020 19:25:08 GMT
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
User-Agent,Accept-Encoding
Content-Type
text/javascript; charset=utf-8
Cache-Control
public
Content-Length
12922
Expires
Wed, 09 Jun 2021 19:25:08 GMT
siteWide
www.renaissancecapital.com/bundles/ 		4 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.renaissancecapital.com/bundles/siteWide?v=q4ajb5vT_zxiyOAiqy0r-q4OnkHjHNmEUeaXhbHcZeE1
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
65ab05d8aa95313e07e98936efdc5cdd4d5f44348d9393efd03a31898e9e8e4b

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Content-Encoding
gzip
Last-Modified
Tue, 09 Jun 2020 19:25:08 GMT
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
User-Agent,Accept-Encoding
Content-Type
text/javascript; charset=utf-8
Cache-Control
public
Content-Length
1686
Expires
Wed, 09 Jun 2021 19:25:08 GMT
angularjs
www.renaissancecapital.com/bundles/ 		156 KB
70 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.renaissancecapital.com/bundles/angularjs?v=0jQdYbHuQN1XgRpTdRNmUENOkFnOKrNlKrloI664oUE1
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
2f5c760efdf649368fbeed39d025958de6ee507b5fc24d13d4f2dc72fd8ad3d2

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Content-Encoding
gzip
Last-Modified
Tue, 09 Jun 2020 19:25:08 GMT
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
User-Agent,Accept-Encoding
Content-Type
text/javascript; charset=utf-8
Cache-Control
public
Transfer-Encoding
chunked
Expires
Wed, 09 Jun 2021 19:25:08 GMT
angular-sanitize.min.js
cdnjs.cloudflare.com/ajax/libs/angular-sanitize/1.5.3/ 		6 KB
3 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://cdnjs.cloudflare.com/ajax/libs/angular-sanitize/1.5.3/angular-sanitize.min.js
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:85e5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
a9d27f5c43bb845c93ace21ffc9617fd7b1a05f527d6da2d927ae57e6374b596
Security Headers
Name Value
Strict-Transport-Security max-age=15780000; includeSubDomains

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:10 GMT
content-encoding
br
vary
Accept-Encoding
cf-cache-status
HIT
age
19221603
status
200
alt-svc
h3-27=":443"; ma=86400
cf-request-id
033c243e2c00000eb3b1b6f200000001
served-in-seconds
0.001
timing-allow-origin
*
last-modified
Thu, 17 May 2018 09:15:29 GMT
server
cloudflare
etag
W/"5afd4831-16c4"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=15780000; includeSubDomains
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=30672000
cf-ray
5a0d3ca9ec350eb3-FRA
expires
Sun, 30 May 2021 19:25:10 GMT
utils
www.renaissancecapital.com/bundles/ 		4 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.renaissancecapital.com/bundles/utils?v=zvCmBMnQXW1K3FW4B3xM6jh3rkL3s1mf4BSOFv0hRw41
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
f97cb042f9f8184d1adf36a6e7eb00833ee542da4361a2a15bd20a1a26dd1c40

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Content-Encoding
gzip
Last-Modified
Tue, 09 Jun 2020 19:25:08 GMT
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
User-Agent,Accept-Encoding
Content-Type
text/javascript; charset=utf-8
Cache-Control
public
Content-Length
1364
Expires
Wed, 09 Jun 2021 19:25:08 GMT
article
www.renaissancecapital.com/bundles/ 		1 KB
1 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.renaissancecapital.com/bundles/article?v=poGOmIw12Bm2WfLXJbIwxbhfuV62SMfRJzN2AtAxBm41
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
d70934b9db100d1fc84f5d74e7d701f68075d1b98289c520d22116d538b6d8c2

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Content-Encoding
gzip
Last-Modified
Tue, 09 Jun 2020 19:25:08 GMT
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
User-Agent,Accept-Encoding
Content-Type
text/javascript; charset=utf-8
Cache-Control
public
Content-Length
848
Expires
Wed, 09 Jun 2021 19:25:08 GMT
gtm.js
www.googletagmanager.com/ 		81 KB
30 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-NQRD4R
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
374ae3030eeb76f51843e2bb91231437982d32e15039b8bd2c8c6d620432e43f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:10 GMT
content-encoding
br
vary
Accept-Encoding
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
30959
x-xss-protection
0
last-modified
Tue, 09 Jun 2020 18:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Tue, 09 Jun 2020 19:25:10 GMT
analytics.js
www.google-analytics.com/ 		45 KB
18 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-NQRD4R
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
2f1fd973e6c48489ae07c467e3278635b856c698d1f502e06af3ab555937deac
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 30 Apr 2020 21:54:13 GMT
server
Golfe2
age
1731
date
Tue, 09 Jun 2020 18:56:19 GMT
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=7200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
18433
expires
Tue, 09 Jun 2020 20:56:19 GMT
js
www.googletagmanager.com/gtag/ 		83 KB
32 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagmanager.com/gtag/js?id=AW-950117991
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-NQRD4R
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
e859249f4eeeb71bf00ae0e62617a3354258eb856570345bc19c2817f4ce1113
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:10 GMT
content-encoding
br
vary
Accept-Encoding
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
33169
x-xss-protection
0
last-modified
Tue, 09 Jun 2020 18:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Tue, 09 Jun 2020 19:25:10 GMT
uwt.js
static.ads-twitter.com/ 		5 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://static.ads-twitter.com/uwt.js
Requested by
Host: t.co
URL: https://t.co/zgTxwhdbsM?amp=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.112.157 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
319949c8c08b86e9c35ea542c0dc0c30cedaa9b8d3d3c3327a36c91aefbd8af5

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:10 GMT
content-encoding
gzip
age
78812
x-cache
HIT
p3p
CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
status
200
content-length
1954
x-served-by
cache-hhn4059-HHN
last-modified
Tue, 23 Jan 2018 20:09:00 GMT
x-timer
S1591730710.135649,VS0,VE0
etag
"b7b33882a4f3ffd5cbf07434f3137166+gzip"
vary
Accept-Encoding,Host
content-type
application/javascript; charset=utf-8
via
1.1 varnish
cache-control
no-cache
accept-ranges
bytes
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://www.google-analytics.com/r/collect?v=1&_v=j82&a=989330262&t=pageview&_s=1&dl=https%3A%2F%2Fwww.renaissancecapital.com%2FIPO-Center%2FNews%2F68733%2FPreclinical-vaccine-biotech-Vaxcyte-sets-...
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-49249493-1&cid=420277392.1591730710&jid=1277299689&_gid=149541781.1591730710&gjid=1431245895&_v=j82&z=1819033172
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-49249493-1&cid=420277392.1591730710&jid=1277299689&_v=j82&z=1819033172
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-49249493-1&cid=420277392.1591730710&jid=1277299689&_v=j82&z=1819033172&slf_rd=1&random=3388323074
42 B
106 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-49249493-1&cid=420277392.1591730710&jid=1277299689&_v=j82&z=1819033172&slf_rd=1&random=3388323074
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 09 Jun 2020 19:25:10 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 09 Jun 2020 19:25:10 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-49249493-1&cid=420277392.1591730710&jid=1277299689&_v=j82&z=1819033172&slf_rd=1&random=3388323074
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
conversion_async.js
www.googleadservices.com/pagead/ 		28 KB
12 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googleadservices.com/pagead/conversion_async.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=AW-950117991
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.207.34 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s24-in-f2.1e100.net
Software
cafe /
Resource Hash
cd34ee8ae406b1662e7ef53583b899f9ccc52d0920127c4716c6944a68916cd5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:10 GMT
content-encoding
gzip
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
10884
x-xss-protection
0
server
cafe
etag
10406653800972162523
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=3600
timing-allow-origin
*
expires
Tue, 09 Jun 2020 19:25:10 GMT
adsct
t.co/i/ 		43 B
368 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://t.co/i/adsct?p_id=Twitter&p_user_id=0&txn_id=o3wux&events=%5B%5B%22pageview%22%2Cnull%5D%5D&tw_sale_amount=0&tw_order_quantity=0&tw_iframe_status=0
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.42.5 , United States, ASN13414 (TWITTER, US),
Reverse DNS
Software
tsa_o /
Resource Hash
ac8778041fdb7f2e08ceb574c9a766247ea26f1a7d90fa854c4efcf4b361a957
Security Headers
Name Value
Strict-Transport-Security max-age=0
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:10 GMT
content-encoding
gzip
x-content-type-options
nosniff
status
200, 200 OK
x-twitter-response-tags
BouncerCompliant
content-length
65
x-xss-protection
0
x-response-time
107
pragma
no-cache
last-modified
Tue, 09 Jun 2020 19:25:10 GMT
server
tsa_o
x-frame-options
SAMEORIGIN
strict-transport-security
max-age=0
content-type
image/gif;charset=utf-8
cache-control
no-cache, no-store, must-revalidate, pre-check=0, post-check=0
x-connection-hash
011a99359d92cea1926a06a1bc3d37f1
x-transaction
00925c6e00d20db7
expires
Tue, 31 Mar 1981 05:00:00 GMT
/
googleads.g.doubleclick.net/pagead/viewthroughconversion/950117991/ 		3 KB
1 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://googleads.g.doubleclick.net/pagead/viewthroughconversion/950117991/?random=1591730710218&cv=9&fst=1591730710218&num=1&bg=ffffff&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2oa5r0&sendb=1&ig=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fwww.renaissancecapital.com%2FIPO-Center%2FNews%2F68733%2FPreclinical-vaccine-biotech-Vaxcyte-sets-terms-for-%24210-million-IPO&ref=https%3A%2F%2Ft.co%2FzgTxwhdbsM%3Famp%3D1&tiba=Preclinical%20vaccine%20biotech%20Vaxcyte%20sets%20terms%20for%20%24210%20million%20IPO%20-%20Renaissance%20Capital&hn=www.googleadservices.com&async=1&rfmt=3&fmt=4
Requested by
Host: www.googleadservices.com
URL: https://www.googleadservices.com/pagead/conversion_async.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f4e315fc8882a0049ee780cc7da731e4d3720df448bff28221f69a753865ae46
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 09 Jun 2020 19:25:10 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
cache-control
no-cache, must-revalidate
content-disposition
attachment; filename="f.txt"
content-type
text/javascript; charset=UTF-8
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
1151
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.google.com/pagead/1p-user-list/950117991/ 		42 B
119 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google.com/pagead/1p-user-list/950117991/?random=1591730710218&cv=9&fst=1591729200000&num=1&bg=ffffff&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2oa5r0&sendb=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fwww.renaissancecapital.com%2FIPO-Center%2FNews%2F68733%2FPreclinical-vaccine-biotech-Vaxcyte-sets-terms-for-%24210-million-IPO&ref=https%3A%2F%2Ft.co%2FzgTxwhdbsM%3Famp%3D1&tiba=Preclinical%20vaccine%20biotech%20Vaxcyte%20sets%20terms%20for%20%24210%20million%20IPO%20-%20Renaissance%20Capital&async=1&fmt=3&is_vtc=1&random=1793704192&resp=GooglemKTybQhCsO&rmt_tld=0&ipr=y
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 09 Jun 2020 19:25:10 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.google.de/pagead/1p-user-list/950117991/ 		42 B
107 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google.de/pagead/1p-user-list/950117991/?random=1591730710218&cv=9&fst=1591729200000&num=1&bg=ffffff&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2oa5r0&sendb=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fwww.renaissancecapital.com%2FIPO-Center%2FNews%2F68733%2FPreclinical-vaccine-biotech-Vaxcyte-sets-terms-for-%24210-million-IPO&ref=https%3A%2F%2Ft.co%2FzgTxwhdbsM%3Famp%3D1&tiba=Preclinical%20vaccine%20biotech%20Vaxcyte%20sets%20terms%20for%20%24210%20million%20IPO%20-%20Renaissance%20Capital&async=1&fmt=3&is_vtc=1&random=1793704192&resp=GooglemKTybQhCsO&rmt_tld=1&ipr=y
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 09 Jun 2020 19:25:10 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
down@2x.png
www.renaissancecapital.com/images/ 		19 KB
19 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.renaissancecapital.com/images/down@2x.png
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
3a6262a6cde89bbc75af582c0c8d84cb967f3881542a42f636515ea81547b1c2

Request headers

Referer
https://www.renaissancecapital.com/Content/css?v=IyI8GkXJ6TtgSf6O5nYzgtx_HMAHAJOZcRCV3GxURNY1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Last-Modified
Fri, 09 Feb 2018 16:46:18 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"c5c2ad81c5a1d31:0"
Content-Type
image/png
Accept-Ranges
bytes
Content-Length
19555
magnifying%20glass.png
www.renaissancecapital.com/Content/Images/ 		708 B
954 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.renaissancecapital.com/Content/Images/magnifying%20glass.png
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
05c32e8b56261336194957ae5a51fa5c640828a86ab8f334c4ab8d59fe47a845

Request headers

Referer
https://www.renaissancecapital.com/Content/css?v=IyI8GkXJ6TtgSf6O5nYzgtx_HMAHAJOZcRCV3GxURNY1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Last-Modified
Fri, 09 Feb 2018 16:46:31 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"bdb9d89c5a1d31:0"
Content-Type
image/png
Accept-Ranges
bytes
Content-Length
708
MuseoSans-700.woff2
www.renaissancecapital.com/webfonts/ 		16 KB
16 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://www.renaissancecapital.com/webfonts/MuseoSans-700.woff2
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
a70443e17c3074d5426456fbf3117bdf91ad4c7916719a856f0390d35c30f09a

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.renaissancecapital.com/Content/css?v=IyI8GkXJ6TtgSf6O5nYzgtx_HMAHAJOZcRCV3GxURNY1
Origin
https://www.renaissancecapital.com

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Last-Modified
Fri, 09 Feb 2018 16:46:09 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"213d557cc5a1d31:0"
Content-Type
application/font-woff2
Accept-Ranges
bytes
Content-Length
16536
fb@2x.png
www.renaissancecapital.com/images/social/ 		15 KB
16 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.renaissancecapital.com/images/social/fb@2x.png
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
d7d138714dcf7f2a2915d28ab0cfb505d8d871e597e2e57b82b1fcb4e3f16976

Request headers

Referer
https://www.renaissancecapital.com/Content/css?v=IyI8GkXJ6TtgSf6O5nYzgtx_HMAHAJOZcRCV3GxURNY1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Last-Modified
Fri, 09 Feb 2018 16:46:17 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"415f6a81c5a1d31:0"
Content-Type
image/png
Accept-Ranges
bytes
Content-Length
15744
tw@2x.png
www.renaissancecapital.com/images/social/ 		16 KB
17 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.renaissancecapital.com/images/social/tw@2x.png
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
a44ff52529dc7ef8f45742a77f10f94d534303adbf47b52f3649f61f8eaaaa50

Request headers

Referer
https://www.renaissancecapital.com/Content/css?v=IyI8GkXJ6TtgSf6O5nYzgtx_HMAHAJOZcRCV3GxURNY1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Last-Modified
Fri, 09 Feb 2018 16:46:17 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"bfc16c81c5a1d31:0"
Content-Type
image/png
Accept-Ranges
bytes
Content-Length
16686
in@2x.png
www.renaissancecapital.com/images/social/ 		16 KB
16 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.renaissancecapital.com/images/social/in@2x.png
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
37078b4b5306604579956571b0fce9aa3b38d4e9523d904edefb2523799a6657

Request headers

Referer
https://www.renaissancecapital.com/Content/css?v=IyI8GkXJ6TtgSf6O5nYzgtx_HMAHAJOZcRCV3GxURNY1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Last-Modified
Fri, 09 Feb 2018 16:46:17 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"415f6a81c5a1d31:0"
Content-Type
image/png
Accept-Ranges
bytes
Content-Length
16006
MuseoSans-900.woff2
www.renaissancecapital.com/webfonts/ 		16 KB
16 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://www.renaissancecapital.com/webfonts/MuseoSans-900.woff2
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
a34c452347a30b943e25ee397ec5e546a786129c92ff024b2a95a153050c2ed8

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.renaissancecapital.com/Content/css?v=IyI8GkXJ6TtgSf6O5nYzgtx_HMAHAJOZcRCV3GxURNY1
Origin
https://www.renaissancecapital.com

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Last-Modified
Fri, 09 Feb 2018 16:46:09 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"939f577cc5a1d31:0"
Content-Type
application/font-woff2
Accept-Ranges
bytes
Content-Length
16252
MuseoSans-300.woff2
www.renaissancecapital.com/webfonts/ 		16 KB
16 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://www.renaissancecapital.com/webfonts/MuseoSans-300.woff2
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
cc5b3f023b0f4cde9e97ab3d6ed3412ce577720a16087df42b567f6fb4577877

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.renaissancecapital.com/Content/css?v=IyI8GkXJ6TtgSf6O5nYzgtx_HMAHAJOZcRCV3GxURNY1
Origin
https://www.renaissancecapital.com

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Last-Modified
Fri, 09 Feb 2018 16:46:09 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"36db527cc5a1d31:0"
Content-Type
application/font-woff2
Accept-Ranges
bytes
Content-Length
16036
MuseoSans-500.woff2
www.renaissancecapital.com/webfonts/ 		16 KB
16 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://www.renaissancecapital.com/webfonts/MuseoSans-500.woff2
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
21797cf51505188bc8c76032d627e2db2326b57d8413710be562cda6e1028746

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.renaissancecapital.com/Content/css?v=IyI8GkXJ6TtgSf6O5nYzgtx_HMAHAJOZcRCV3GxURNY1
Origin
https://www.renaissancecapital.com

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Last-Modified
Fri, 09 Feb 2018 16:46:09 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"36db527cc5a1d31:0"
Content-Type
application/font-woff2
Accept-Ranges
bytes
Content-Length
16368
fontawesome-webfont.woff2
www.renaissancecapital.com/fonts/ 		75 KB
76 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://www.renaissancecapital.com/fonts/fontawesome-webfont.woff2?v=4.7.0
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
2adefcbc041e7d18fcf2d417879dc5a09997aa64d675b7a3c4b6ce33da13f3fe

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.renaissancecapital.com/Content/css?v=IyI8GkXJ6TtgSf6O5nYzgtx_HMAHAJOZcRCV3GxURNY1
Origin
https://www.renaissancecapital.com

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Last-Modified
Fri, 09 Feb 2018 16:46:09 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"aed9947cc5a1d31:0"
Content-Type
application/font-woff2
Accept-Ranges
bytes
Content-Length
77160
MuseoSans-100.woff2
www.renaissancecapital.com/webfonts/ 		15 KB
16 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://www.renaissancecapital.com/webfonts/MuseoSans-100.woff2
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
2b058cf41e00c51905eca600534e77e02e45bb599d9948a58a7f536c569b1560

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.renaissancecapital.com/Content/css?v=IyI8GkXJ6TtgSf6O5nYzgtx_HMAHAJOZcRCV3GxURNY1
Origin
https://www.renaissancecapital.com

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Last-Modified
Fri, 09 Feb 2018 16:46:09 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"ee78507cc5a1d31:0"
Content-Type
application/font-woff2
Accept-Ranges
bytes
Content-Length
15788
insight.min.js
snap.licdn.com/li.lms-analytics/ 		3 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://snap.licdn.com/li.lms-analytics/insight.min.js
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:10c:382::25ea , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
41dd5e421fe221a7d2921d6fa2b36e8b01a9f2c054aaef5fad866fe896c1d1e0

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:10 GMT
Content-Encoding
gzip
Last-Modified
Mon, 07 Oct 2019 16:41:31 GMT
X-CDN
AKAM
Vary
Accept-Encoding
Content-Type
application/x-javascript;charset=utf-8
Cache-Control
max-age=42399
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
1576
preload.js
front.optimonk.com/public/73473/js/ 		37 KB
9 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://front.optimonk.com/public/73473/js/preload.js
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
46.101.154.21 Frankfurt am Main, Germany, ASN14061 (DIGITALOCEAN-ASN, US),
Reverse DNS
Software
nginx /
Resource Hash
7d5846d856710e6934187c924460a211e46d0b05edc250f6c30467a9bfae2233
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:10 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
nginx
status
200
etag
W/"9540-+d0d4P8HlA9Z9IWzHxMJK+kbZoA"
x-download-options
noopen
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=1350
strict-transport-security
max-age=15552000; includeSubDomains
x-dns-prefetch-control
off
vary
Accept-Encoding
x-xss-protection
1; mode=block
collect
px.ads.linkedin.com/
Redirect Chain
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=113542&url=https%3A%2F%2Fwww.renaissancecapital.com%2FIPO-Center%2FNews%2F68733%2FPreclinical-vaccine-biotech-Vaxcyte-sets-terms-for-%24210-millio...
  • https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D113542%26url%3Dhttps%253A%252F%252Fwww.renaissancecapital.com%252FIPO-Center%252F...
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=113542&url=https%3A%2F%2Fwww.renaissancecapital.com%2FIPO-Center%2FNews%2F68733%2FPreclinical-vaccine-biotech-Vaxcyte-sets-terms-for-%24210-millio...
0
80 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=113542&url=https%3A%2F%2Fwww.renaissancecapital.com%2FIPO-Center%2FNews%2F68733%2FPreclinical-vaccine-biotech-Vaxcyte-sets-terms-for-%24210-million-IPO&time=1591730710578&liSync=true
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a05:f500:11:101::b93f:9005 , Ireland, ASN14413 (LINKEDIN, US),
Reverse DNS
Software
Play /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:11 GMT
server
Play
linkedin-action
1
x-li-fabric
prod-lor1
status
200
x-li-proto
http/2
x-li-pop
prod-tln1
content-type
application/javascript
content-length
0
x-li-uuid
79dd+aX2FhYAxukuyioAAA==

Redirect headers

strict-transport-security
max-age=2592000
x-content-type-options
nosniff
linkedin-action
1
status
302
content-length
0
x-li-uuid
zYDQ8qX2FhaA1wyJpSsAAA==
pragma
no-cache
x-li-pop
afd-prod-lor1
x-msedge-ref
Ref A: 4009E6BA98C34D6695802560F8858486 Ref B: FRAEDGE1116 Ref C: 2020-06-09T19:25:10Z
date
Tue, 09 Jun 2020 19:25:11 GMT
expect-ct
max-age=86400, report-uri="https://www.linkedin.com/platform-telemetry/ct"
x-frame-options
sameorigin
x-li-fabric
prod-lor1
location
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=113542&url=https%3A%2F%2Fwww.renaissancecapital.com%2FIPO-Center%2FNews%2F68733%2FPreclinical-vaccine-biotech-Vaxcyte-sets-terms-for-%24210-million-IPO&time=1591730710578&liSync=true
x-xss-protection
1; mode=block
cache-control
no-cache, no-store
content-security-policy
default-src *; connect-src 'self' https://media-src.linkedin.com/media/ www.linkedin.com s.c.lnkd.licdn.com m.c.lnkd.licdn.com s.c.exp1.licdn.com s.c.exp2.licdn.com m.c.exp1.licdn.com m.c.exp2.licdn.com wss://*.linkedin.com dms.licdn.com https://dpm.demdex.net/id https://lnkd.demdex.net/event blob: static.licdn.com static-exp1.licdn.com static-exp2.licdn.com static-exp3.licdn.com media.licdn.com media-exp1.licdn.com media-exp2.licdn.com media-exp3.licdn.com; img-src data: blob: *; font-src data: *; style-src 'unsafe-inline' 'self' static-src.linkedin.com *.licdn.com; script-src 'report-sample' 'unsafe-inline' 'unsafe-eval' 'self' spdy.linkedin.com static-src.linkedin.com *.ads.linkedin.com *.licdn.com static.chartbeat.com www.google-analytics.com ssl.google-analytics.com bcvipva02.rightnowtech.com www.bizographics.com sjs.bizographics.com js.bizographics.com d.la4-c1-was.salesforceliveagent.com slideshare.www.linkedin.com https://snap.licdn.com/li.lms-analytics/insight.min.js platform.linkedin.com platform-akam.linkedin.com platform-ecst.linkedin.com platform-azur.linkedin.com; object-src 'none'; media-src blob: *; child-src blob: lnkd-communities: voyager: *; frame-ancestors 'self'
x-li-proto
http/2
expires
Thu, 01 Jan 1970 00:00:00 GMT
load
front.optimonk.com/public/73473/js/ 		579 KB
172 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://front.optimonk.com/public/73473/js/load
Requested by
Host: front.optimonk.com
URL: https://front.optimonk.com/public/73473/js/preload.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
46.101.154.21 Frankfurt am Main, Germany, ASN14061 (DIGITALOCEAN-ASN, US),
Reverse DNS
Software
nginx /
Resource Hash
b2eaebb04c0d4fd2c75af8fa88d981cd5ab0b6b915a765183010a6e85c4d227a
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-type
application/x-www-form-urlencoded

Response headers

date
Tue, 09 Jun 2020 19:25:10 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
nginx
status
200
etag
W/"90d64-7NtiYryo03vZZzkyhK0fzwzrFpo"
x-download-options
noopen
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
no-cache
strict-transport-security
max-age=15552000; includeSubDomains
x-dns-prefetch-control
off
vary
Accept-Encoding
x-xss-protection
1; mode=block
adsct
analytics.twitter.com/i/ 		31 B
651 B 		Script
General
Check archive.org
Download Go to
Full URL
https://analytics.twitter.com/i/adsct?p_id=Twitter&p_user_id=0&txn_id=o3wux&events=%5B%5B%22pageview%22%2Cnull%5D%5D&tw_sale_amount=0&tw_order_quantity=0&tw_iframe_status=0&tpx_cb=twttr.conversion.loadPixels&tw_document_href=https%3A%2F%2Fwww.renaissancecapital.com%2FIPO-Center%2FNews%2F68733%2FPreclinical-vaccine-biotech-Vaxcyte-sets-terms-for-%24210-million-IPO
Requested by
Host: static.ads-twitter.com
URL: https://static.ads-twitter.com/uwt.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.42.195 , United States, ASN13414 (TWITTER, US),
Reverse DNS
Software
tsa_o /
Resource Hash
df3e003cc30e9bdd0313100e8ee5d468070b4b34d11ad355f276a356d4b9c7bf
Security Headers
Name Value
Strict-Transport-Security max-age=631138519
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:10 GMT
content-encoding
gzip
x-content-type-options
nosniff
p3p
CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
status
200, 200 OK
x-twitter-response-tags
BouncerCompliant
strict-transport-security
max-age=631138519
content-length
57
x-xss-protection
0
x-response-time
122
pragma
no-cache
last-modified
Tue, 09 Jun 2020 19:25:10 GMT
server
tsa_o
x-frame-options
SAMEORIGIN
content-type
application/javascript;charset=utf-8
cache-control
no-cache, no-store, must-revalidate, pre-check=0, post-check=0
x-connection-hash
4f642cfe3054da1426c2b41ebc6c9b45
x-transaction
002702ea00ebc844
expires
Tue, 31 Mar 1981 05:00:00 GMT
Article
data.renaissancecapital.com/api/ 		1 KB
2 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://data.renaissancecapital.com/api/Article?newskey=68733
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/bundles/angularjs?v=0jQdYbHuQN1XgRpTdRNmUENOkFnOKrNlKrloI664oUE1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
ffdfa491d0a1b0fdcffa99781f76eb41e80aae918568258eb6f78e23737ddbce

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 09 Jun 2020 19:25:09 GMT
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Access-Control-Allow-Methods
GET, OPTIONS
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Access-Control-Allow-Headers
Content-Type
Content-Length
1238
Expires
-1
marketwatch-header.png
www.renaissancecapital.com/images/ 		25 KB
25 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.renaissancecapital.com/images/marketwatch-header.png
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
2a7870e21434c447b8be58caaec3db8beb1f18dfff58235530020ea39cbc7e9c

Request headers

Referer
https://www.renaissancecapital.com/Content/css?v=IyI8GkXJ6TtgSf6O5nYzgtx_HMAHAJOZcRCV3GxURNY1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:07 GMT
Last-Modified
Fri, 09 Feb 2018 16:46:14 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"2d86cd7fc5a1d31:0"
Content-Type
image/png
Accept-Ranges
bytes
Content-Length
25467
content.html
cdn-content.optimonk.com/public/73473/5d71511c21e1790011d76297/ 		31 KB
4 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://cdn-content.optimonk.com/public/73473/5d71511c21e1790011d76297/content.html?v=1568128050
Requested by
Host: t.co
URL: https://t.co/zgTxwhdbsM?amp=1
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
195.181.175.49 Frankfurt am Main, Germany, ASN60068 (CDN77, GB),
Reverse DNS
frankfurt-47.cdn77.com
Software
CDN77-Turbo /
Resource Hash
b45f167c88117abd607573d62e4d7dce1f88af716816c1e595063efce122e094

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:11 GMT
content-encoding
br
vary
Origin, Access-Control-Request-Headers, Access-Control-Request-Method
x-amz-request-id
A3F4E5F1DE153F30
x-edge-location
frankfurtDE
x-cache
HIT
status
200
x-age
353345
x-amz-id-2
kDz6C9i8+f99uvI1rK6U2SZPto+XWTHqLaMpaB4S7Uf/I7LU2UsRbwy6u4EQxJakCp8TG6D8OWc=
last-modified
Tue, 10 Sep 2019 15:07:31 GMT
server
CDN77-Turbo
etag
W/"2c9fc5066d9fb8359f42eb54bccc56e1"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
text/html
access-control-allow-origin
*
x-edge-ip
195.181.175.47
optimonk.min.css
cdn-static.optimonk.com/bundles/wseoptimonk/css/ 		15 KB
2 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://cdn-static.optimonk.com/bundles/wseoptimonk/css/optimonk.min.css?v=213
Requested by
Host: t.co
URL: https://t.co/zgTxwhdbsM?amp=1
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
195.181.175.51 Frankfurt am Main, Germany, ASN60068 (CDN77, GB),
Reverse DNS
frankfurt-50.cdn77.com
Software
CDN77-Turbo /
Resource Hash
fe69f27e8d524113d66ad6a9f76747a7ccc18c4d599262590d0a85fb76469eb5

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:11 GMT
content-encoding
br
last-modified
Fri, 21 Jun 2019 09:56:17 GMT
server
CDN77-Turbo
x-edge-location
frankfurtDE
vary
Accept-Encoding
x-cache
HIT
content-type
text/css
status
200
cache-control
max-age=31536000, public
x-edge-ip
195.181.175.50
x-age
11001788
expires
Tue, 02 Feb 2021 11:22:03 GMT
om.base.css
front.optimonk.com/assets/css/ 		263 KB
24 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://front.optimonk.com/assets/css/om.base.css?v=e6aab445448a07fb630d
Requested by
Host: t.co
URL: https://t.co/zgTxwhdbsM?amp=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
46.101.154.21 Frankfurt am Main, Germany, ASN14061 (DIGITALOCEAN-ASN, US),
Reverse DNS
Software
nginx /
Resource Hash
ef0d5cff42e78aefc27ca2110066967888b998d9349d3efd1164a2bd509c2df2
Security Headers
Name Value
Strict-Transport-Security max-age=15552000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:10 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
nginx
status
200
etag
W/"41a4c-ipI61V5sVzBwcvr4sBkGYktxv7A"
x-download-options
noopen
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=604800
strict-transport-security
max-age=15552000; includeSubDomains
x-dns-prefetch-control
off
vary
Accept-Encoding
x-xss-protection
1; mode=block
font-awesome.min.css
maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/ 		30 KB
7 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css
Requested by
Host: t.co
URL: https://t.co/zgTxwhdbsM?amp=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4de0:ac19::1:b:2a , Netherlands, ASN20446 (HIGHWINDS3, US),
Reverse DNS
Software
/
Resource Hash
799aeb25cc0373fdee0e1b1db7ad6c2f6a0e058dfadaa3379689f583213190bd
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Wed, 12 Dec 2018 18:35:20 GMT
status
200
etag
"1544639720"
vary
Accept-Encoding
x-cache
HIT
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
content-length
7050
css
fonts.googleapis.com/ 		27 KB
1 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://fonts.googleapis.com/css?family=Gruppo:400%7COpen+Sans:300,300i,400,400i,600,600i,700,700i,800,800i&display=swap
Requested by
Host: t.co
URL: https://t.co/zgTxwhdbsM?amp=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:801::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e83cdf7a38074127ed9f57321ecb6c785ab6fd3c44e7c4e7e5db3fcfb8b7f8b7
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Tue, 09 Jun 2020 19:25:11 GMT
server
ESF
date
Tue, 09 Jun 2020 19:25:11 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Tue, 09 Jun 2020 19:25:11 GMT
RC_Corp_Logo_blue_1567706832177.png
editor-upload-cdn.optimonk.com/userImages/73473/5d714e65a5cb6c0011388e50/ 		52 KB
52 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://editor-upload-cdn.optimonk.com/userImages/73473/5d714e65a5cb6c0011388e50/RC_Corp_Logo_blue_1567706832177.png
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
195.181.175.46 Frankfurt am Main, Germany, ASN60068 (CDN77, GB),
Reverse DNS
frankfurt-44.cdn77.com
Software
CDN77-Turbo /
Resource Hash
2cab9ad6402e21ff5a1333f6958ef72e305294415fac00012ae132cf8bc084fb

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:11 GMT
last-modified
Thu, 05 Sep 2019 18:07:17 GMT
server
CDN77-Turbo
x-amz-request-id
8EB1627EA7E55D1B
x-edge-location
frankfurtDE
etag
"c9a9642fed989de3afc504835f56c98a"
x-cache
HIT
content-type
application/octet-stream
status
200
x-edge-ip
195.181.175.44
x-age
338404
accept-ranges
bytes
content-length
52780
x-amz-id-2
akFnLvX+IBn4yLH7t0gurg+BqYGGB7loValZMwHPAZNgeSy9BOClufGIgmEQwY7vYWzm0sA7JRQ=
bigstock-Young-In_1567707190273_edit2_1567707604338.jpg
editor-upload-cdn.optimonk.com/userImages/73473/5d71511c21e1790011d76297/ 		88 KB
88 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://editor-upload-cdn.optimonk.com/userImages/73473/5d71511c21e1790011d76297/bigstock-Young-In_1567707190273_edit2_1567707604338.jpg
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
195.181.175.46 Frankfurt am Main, Germany, ASN60068 (CDN77, GB),
Reverse DNS
frankfurt-44.cdn77.com
Software
CDN77-Turbo /
Resource Hash
2f972b56aeda24be8f32532c5d6350a8eefe2c8d9b3f2fdef18a8a1e3d395b0e

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:11 GMT
last-modified
Thu, 05 Sep 2019 18:20:07 GMT
server
CDN77-Turbo
x-amz-request-id
E9DC8AB86B9F0AA0
x-edge-location
frankfurtDE
etag
"18a1703a97065bf14371edac89098d2b"
x-cache
HIT
content-type
application/octet-stream
status
200
x-edge-ip
195.181.175.44
x-age
338404
accept-ranges
bytes
content-length
90092
x-amz-id-2
UEsJPDOk/du1OW3xMvn0o6Pzz51fRH3Vg0/l1cJ3l7wXtJP/CYHWtFFMLKnGwM1Ph/TfUUywZ0U=
WwkfxPmzE06v_ZW1XnrBGoIAUA.woff2
fonts.gstatic.com/s/gruppo/v10/ 		17 KB
17 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://fonts.gstatic.com/s/gruppo/v10/WwkfxPmzE06v_ZW1XnrBGoIAUA.woff2
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
199bb0d0613ad2bf31a7a3502b80e80ed4f879bb73ae563cbf67760f502328e0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://fonts.googleapis.com/css?family=Gruppo:400%7COpen+Sans:300,300i,400,400i,600,600i,700,700i,800,800i&display=swap
Origin
https://www.renaissancecapital.com

Response headers

date
Wed, 27 May 2020 10:55:10 GMT
x-content-type-options
nosniff
last-modified
Tue, 16 Jul 2019 03:44:15 GMT
server
sffe
age
1153801
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
16988
x-xss-protection
0
expires
Thu, 27 May 2021 10:55:10 GMT
mem5YaGs126MiZpBA-UN_r8OUuhpKKSTjw.woff2
fonts.gstatic.com/s/opensans/v17/ 		9 KB
9 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://fonts.gstatic.com/s/opensans/v17/mem5YaGs126MiZpBA-UN_r8OUuhpKKSTjw.woff2
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5e261f7e11c39ff6f4c8fe884e5c9de2fa15f29085a1adefdd36603ef2e23c00
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://fonts.googleapis.com/css?family=Gruppo:400%7COpen+Sans:300,300i,400,400i,600,600i,700,700i,800,800i&display=swap
Origin
https://www.renaissancecapital.com

Response headers

date
Sat, 16 May 2020 07:38:14 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 19:30:37 GMT
server
sffe
age
2116017
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
9016
x-xss-protection
0
expires
Sun, 16 May 2021 07:38:14 GMT
memnYaGs126MiZpBA-UFUKWyV9hrIqOxjaPX.woff2
fonts.gstatic.com/s/opensans/v17/ 		10 KB
10 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://fonts.gstatic.com/s/opensans/v17/memnYaGs126MiZpBA-UFUKWyV9hrIqOxjaPX.woff2
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
41c93545a4e2a1a46bca581d80fec8c8da014e13b310c65d694e4af30c7da9bd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://fonts.googleapis.com/css?family=Gruppo:400%7COpen+Sans:300,300i,400,400i,600,600i,700,700i,800,800i&display=swap
Origin
https://www.renaissancecapital.com

Response headers

date
Tue, 19 May 2020 14:26:41 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 19:30:56 GMT
server
sffe
age
1832310
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
9744
x-xss-protection
0
expires
Wed, 19 May 2021 14:26:41 GMT
mem8YaGs126MiZpBA-UFVZ0bf8pkAg.woff2
fonts.gstatic.com/s/opensans/v17/ 		9 KB
9 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://fonts.gstatic.com/s/opensans/v17/mem8YaGs126MiZpBA-UFVZ0bf8pkAg.woff2
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
54c64f3c66372027154f01fc9f24b4e25fdfe405b70d1994c79abbc2576ff775
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://fonts.googleapis.com/css?family=Gruppo:400%7COpen+Sans:300,300i,400,400i,600,600i,700,700i,800,800i&display=swap
Origin
https://www.renaissancecapital.com

Response headers

date
Fri, 22 May 2020 20:44:13 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 19:30:49 GMT
server
sffe
age
1550458
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
9132
x-xss-protection
0
expires
Sat, 22 May 2021 20:44:13 GMT
mem6YaGs126MiZpBA-UFUK0Zdc1GAK6b.woff2
fonts.gstatic.com/s/opensans/v17/ 		10 KB
10 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://fonts.gstatic.com/s/opensans/v17/mem6YaGs126MiZpBA-UFUK0Zdc1GAK6b.woff2
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ffcde34efda55a63cb66dbec4bf10acb531014d581e2d8e511836b84e08c2305
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://fonts.googleapis.com/css?family=Gruppo:400%7COpen+Sans:300,300i,400,400i,600,600i,700,700i,800,800i&display=swap
Origin
https://www.renaissancecapital.com

Response headers

date
Sat, 16 May 2020 07:45:39 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 19:31:02 GMT
server
sffe
age
2115572
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
9728
x-xss-protection
0
expires
Sun, 16 May 2021 07:45:39 GMT
mem5YaGs126MiZpBA-UNirkOUuhpKKSTjw.woff2
fonts.gstatic.com/s/opensans/v17/ 		9 KB
9 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://fonts.gstatic.com/s/opensans/v17/mem5YaGs126MiZpBA-UNirkOUuhpKKSTjw.woff2
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b8e23a845bc6b7fd417d29182e0e38d353e64b5e12e06bb1de2b5ce063db1dcc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://fonts.googleapis.com/css?family=Gruppo:400%7COpen+Sans:300,300i,400,400i,600,600i,700,700i,800,800i&display=swap
Origin
https://www.renaissancecapital.com

Response headers

date
Wed, 20 May 2020 07:37:44 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 19:30:44 GMT
server
sffe
age
1770447
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
9180
x-xss-protection
0
expires
Thu, 20 May 2021 07:37:44 GMT
memnYaGs126MiZpBA-UFUKXGUdhrIqOxjaPX.woff2
fonts.gstatic.com/s/opensans/v17/ 		9 KB
10 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://fonts.gstatic.com/s/opensans/v17/memnYaGs126MiZpBA-UFUKXGUdhrIqOxjaPX.woff2
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
7a4cbe29c8a1c6c2e29b887fd58d9a02b64e7bd113acc77d370b547b9f51545d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://fonts.googleapis.com/css?family=Gruppo:400%7COpen+Sans:300,300i,400,400i,600,600i,700,700i,800,800i&display=swap
Origin
https://www.renaissancecapital.com

Response headers

date
Mon, 08 Jun 2020 21:31:37 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 19:30:59 GMT
server
sffe
age
78814
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
9684
x-xss-protection
0
expires
Tue, 08 Jun 2021 21:31:37 GMT
mem5YaGs126MiZpBA-UN7rgOUuhpKKSTjw.woff2
fonts.gstatic.com/s/opensans/v17/ 		9 KB
9 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://fonts.gstatic.com/s/opensans/v17/mem5YaGs126MiZpBA-UN7rgOUuhpKKSTjw.woff2
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a48a6e4b14fe55f750c0a3dfb5a6f4941bdc06af0aa542b90de25c30c2b4625c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://fonts.googleapis.com/css?family=Gruppo:400%7COpen+Sans:300,300i,400,400i,600,600i,700,700i,800,800i&display=swap
Origin
https://www.renaissancecapital.com

Response headers

date
Wed, 20 May 2020 07:39:04 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 19:31:11 GMT
server
sffe
age
1770367
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
9080
x-xss-protection
0
expires
Thu, 20 May 2021 07:39:04 GMT
memnYaGs126MiZpBA-UFUKWiUNhrIqOxjaPX.woff2
fonts.gstatic.com/s/opensans/v17/ 		9 KB
9 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://fonts.gstatic.com/s/opensans/v17/memnYaGs126MiZpBA-UFUKWiUNhrIqOxjaPX.woff2
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
0d6762417b3b91c64f1d9c9689deb17a1120dfaf507b547b6bf5a11fdf0968a8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://fonts.googleapis.com/css?family=Gruppo:400%7COpen+Sans:300,300i,400,400i,600,600i,700,700i,800,800i&display=swap
Origin
https://www.renaissancecapital.com

Response headers

date
Thu, 21 May 2020 14:41:49 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 19:31:15 GMT
server
sffe
age
1658602
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
9416
x-xss-protection
0
expires
Fri, 21 May 2021 14:41:49 GMT
mem5YaGs126MiZpBA-UN8rsOUuhpKKSTjw.woff2
fonts.gstatic.com/s/opensans/v17/ 		9 KB
9 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://fonts.gstatic.com/s/opensans/v17/mem5YaGs126MiZpBA-UN8rsOUuhpKKSTjw.woff2
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
d8ccc36d648469ae72535a1ec5e23def10a53deff594eabfe2a6fa5d4ee4ce2e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://fonts.googleapis.com/css?family=Gruppo:400%7COpen+Sans:300,300i,400,400i,600,600i,700,700i,800,800i&display=swap
Origin
https://www.renaissancecapital.com

Response headers

date
Tue, 19 May 2020 00:14:58 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 19:30:53 GMT
server
sffe
age
1883413
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
9192
x-xss-protection
0
expires
Wed, 19 May 2021 00:14:58 GMT
fontawesome-webfont.woff2
maxcdn.bootstrapcdn.com/font-awesome/4.7.0/fonts/ 		75 KB
76 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/fonts/fontawesome-webfont.woff2?v=4.7.0
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4de0:ac19::1:b:2a , Netherlands, ASN20446 (HIGHWINDS3, US),
Reverse DNS
Software
/
Resource Hash
2adefcbc041e7d18fcf2d417879dc5a09997aa64d675b7a3c4b6ce33da13f3fe
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css
Origin
https://www.renaissancecapital.com

Response headers

date
Tue, 09 Jun 2020 19:25:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Wed, 12 Dec 2018 18:36:18 GMT
status
200
etag
"1544639778"
vary
Accept-Encoding
x-cache
HIT
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
content-length
77171
roundtrip.js
s.adroll.com/j/ 		35 KB
12 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://s.adroll.com/j/roundtrip.js
Requested by
Host: www.renaissancecapital.com
URL: https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
184.51.8.183 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
0b5b4a374d6dfb06f111c288ba9042d5c4e1305b3da110bea8116f3090bce2e5

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
ehJgGpzGzAbK8GzMvrCmhGB9QIvRjX3O
Content-Encoding
gzip
ETag
"493863a9069eb4663881ed7b590bc370"
x-amz-request-id
B49486DEEB498ED1
x-amz-server-side-encryption
AES256
Connection
keep-alive
Vary
Accept-Encoding
Content-Length
11133
x-amz-id-2
gg+gOV6/QXWRr7fvsYHAMlAhaKbktvKLVt0yWS7Tv1haYqRmKjpmMXV3GKgt9n+aGeucvgmCLGg=
Last-Modified
Tue, 02 Jun 2020 21:58:20 GMT
Server
AmazonS3
Date
Tue, 09 Jun 2020 19:25:11 GMT
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
text/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=3600, must-revalidate
Access-Control-Allow-Credentials
false
Accept-Ranges
bytes
Access-Control-Allow-Headers
*
index.js
s.adroll.com/j/exp/
Redirect Chain
  • https://s.adroll.com/j/exp/CQCUUD3XQNCLZLODBFVNZR/index.js
  • https://s.adroll.com/j/exp/index.js
28 B
747 B 		Script
General
Check archive.org
Download Go to
Full URL
https://s.adroll.com/j/exp/index.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
184.51.8.183 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
f59e5f34a941183aacaed25322ac0856628493c2cfd936ded3fddc0a49510e52

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
MvaZYW7xXR9M9hUcWDgUVAWVyUlL21ST
Content-Encoding
gzip
ETag
"5816cced8568d223aa09d889f300692b"
x-amz-request-id
63FFDB6A815034E2
x-amz-server-side-encryption
AES256
Connection
keep-alive
Vary
Accept-Encoding
Content-Length
48
x-amz-id-2
/w04ADn7RWvZepNTExcw5yw+7/Tmr6tKCx80RU4bWu+Hz2olqFblqhFw8oMq0kiAFsgqdhw6YY0=
Last-Modified
Fri, 05 Jun 2020 15:32:25 GMT
Server
AmazonS3
Date
Tue, 09 Jun 2020 19:25:11 GMT
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
false
Accept-Ranges
bytes
Access-Control-Allow-Headers
*

Redirect headers

Date
Tue, 09 Jun 2020 19:25:11 GMT
Server
AkamaiGHost
Location
https://s.adroll.com/j/exp/index.js
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
false
Connection
keep-alive
Access-Control-Allow-Headers
*
Content-Length
0
index.js
s.adroll.com/j/pre/CQCUUD3XQNCLZLODBFVNZR/Q5XIDRTMVZBNBLVKBMVXK5/ 		1 KB
1 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://s.adroll.com/j/pre/CQCUUD3XQNCLZLODBFVNZR/Q5XIDRTMVZBNBLVKBMVXK5/index.js
Requested by
Host: s.adroll.com
URL: https://s.adroll.com/j/roundtrip.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
184.51.8.183 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
cbce85e96b7752208ce15a09ea4d5a58b792edc9e77f1c5ccf46c01935970f9d

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
2mXzODJtc5.24PGn9HIFkHg8PBvn96B9
Content-Encoding
gzip
ETag
"3996d65282dd996ee0d7d4c90c139158"
x-amz-request-id
ECA06BA4F022C3A4
x-amz-server-side-encryption
AES256
Connection
keep-alive
Vary
Accept-Encoding
Content-Length
635
x-amz-id-2
WNX3gT6OCFNCEKQpxbaVOetWzX4s1puOG8lsP/ia8HwE59x9UJOqPQftRobnJA3zsfTEfGWpYcM=
Last-Modified
Tue, 09 Jun 2020 17:11:51 GMT
Server
AmazonS3
Date
Tue, 09 Jun 2020 19:25:11 GMT
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
text/javascript; charset=utf-8
Access-Control-Allow-Origin
*
Cache-Control
max-age=3600, must-revalidate
Access-Control-Allow-Credentials
false
Accept-Ranges
bytes
Access-Control-Allow-Headers
*
/
d.adroll.com/consent/check/CQCUUD3XQNCLZLODBFVNZR/
Redirect Chain
  • https://d.adroll.mgr.consensu.org/consent/iabcheck/CQCUUD3XQNCLZLODBFVNZR?_s=1674f602e054294b4460063715d7ed6e&_b=2
  • https://d.adroll.com/consent/check/CQCUUD3XQNCLZLODBFVNZR/?_s=1674f602e054294b4460063715d7ed6e&_b=2
122 B
214 B 		Script
General
Check archive.org
Download Go to
Full URL
https://d.adroll.com/consent/check/CQCUUD3XQNCLZLODBFVNZR/?_s=1674f602e054294b4460063715d7ed6e&_b=2
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
99.81.9.236 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-99-81-9-236.eu-west-1.compute.amazonaws.com
Software
nginx/1.16.1 /
Resource Hash
2dee4365bf506fc6e319f03812a71faa4a9a54d5245837c2f2e97a207ab870f8

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status
200
date
Tue, 09 Jun 2020 19:25:11 GMT
server
nginx/1.16.1
content-length
122
content-type
application/javascript

Redirect headers

status
302
date
Tue, 09 Jun 2020 19:25:11 GMT
server
nginx/1.16.1
content-length
105
location
https://d.adroll.com/consent/check/CQCUUD3XQNCLZLODBFVNZR/?_s=1674f602e054294b4460063715d7ed6e&_b=2
PCVX_logo.jpg
www.renaissancecapital.com/logos/ 		6 KB
7 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.renaissancecapital.com/logos/PCVX_logo.jpg
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_CBC
Server
173.251.78.140 Nutley, United States, ASN6128 (CABLE-NET-1, US),
Reverse DNS
renaissancecapital.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
8e3a49f9bdeceabdf93eabe99e32cf4ed9a048b2ef9e2dc844ffadaa8b514da6

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 09 Jun 2020 19:25:09 GMT
Last-Modified
Fri, 22 May 2020 21:22:15 GMT
Server
Microsoft-IIS/8.5
X-Powered-By
ASP.NET
ETag
"cc3c5107f30d61:0"
Content-Type
image/jpeg
Accept-Ranges
bytes
Content-Length
6498
consent.js
s.adroll.com/j/ 		243 KB
33 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://s.adroll.com/j/consent.js
Requested by
Host: s.adroll.com
URL: https://s.adroll.com/j/roundtrip.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
184.51.8.183 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
f82c9f099656346f543c66ba009bd5f18010c7b41ad43d47a7f762121ad4496d

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
W7pJTDq0578OcjyRZxtRH_BjDuWCGgRc
Content-Encoding
gzip
ETag
"2f9f76c2d377be42af05cdf34c632618"
x-amz-request-id
C5CB11FA2891D5FB
x-amz-server-side-encryption
AES256
Connection
keep-alive
Vary
Accept-Encoding
Content-Length
33195
x-amz-id-2
xvDuzhmafYXOulMfcltPByepfW69qHQWdG5Ym3MZlL+9sl8jZLq//WEZRkSp6xPBek9wYUVR3VI=
Last-Modified
Tue, 19 Nov 2019 20:42:26 GMT
Server
AmazonS3
Date
Tue, 09 Jun 2020 19:25:11 GMT
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=300, must-revalidate
Access-Control-Allow-Credentials
false
Accept-Ranges
bytes
Access-Control-Allow-Headers
*
hod
d.adroll.com/consent/ 		42 B
180 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://d.adroll.com/consent/hod?_e=view_banner&_s=1674f602e054294b4460063715d7ed6e&_b=2.1&_a=CQCUUD3XQNCLZLODBFVNZR
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
99.81.9.236 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-99-81-9-236.eu-west-1.compute.amazonaws.com
Software
nginx/1.16.1 /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status
200
date
Tue, 09 Jun 2020 19:25:11 GMT
cache-control
no-transform,public,max-age=300,s-maxage=900
server
nginx/1.16.1
content-length
42
vary
Cookie
content-type
image/gif
fbevents.js
connect.facebook.net/en_US/ 		131 KB
31 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: t.co
URL: https://t.co/zgTxwhdbsM?amp=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f058:f:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
4cb61e44bf63a9e090e666898cd04d382e4c33b55b62cc5e9ff7dab055fbf787
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-27=":443"; ma=3600
content-length
31766
x-xss-protection
0
pragma
public
x-fb-debug
/ikXOm8K/3uLxyq74GmHd2hKh+PzLOG1iJrwVJACxo6gewFYjYe+yBGyoZMSjL4by+O6+Skfu94CNh/c4cccZg==
x-fb-trip-id
1679558926
x-frame-options
DENY
date
Tue, 09 Jun 2020 19:25:20 GMT, Tue, 09 Jun 2020 19:25:20 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
expires
Sat, 01 Jan 2000 00:00:00 GMT
1490749274588634
connect.facebook.net/signals/config/ 		516 KB
130 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://connect.facebook.net/signals/config/1490749274588634?v=2.9.18&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f058:f:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
4cdf34bcbb595fc889ed1b042e5cf71775398c7227c52ab15222e4c26fa08370
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-27=":443"; ma=3600
x-xss-protection
0
pragma
public
x-fb-debug
GVolzlVcZuoLvCcaqmewb3meH2687c+WOCL0aMMbsBD+X5LXBCeoISkuQUJM3oYHfEMqKxjw//PgrGqeoFRMHA==
x-fb-trip-id
1679558926
x-frame-options
DENY
date
Tue, 09 Jun 2020 19:25:20 GMT, Tue, 09 Jun 2020 19:25:20 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
/
www.facebook.com/tr/ 		44 B
258 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.facebook.com/tr/?id=1490749274588634&ev=PageView&dl=https%3A%2F%2Fwww.renaissancecapital.com%2FIPO-Center%2FNews%2F68733%2FPreclinical-vaccine-biotech-Vaxcyte-sets-terms-for-%24210-million-IPO&rl=https%3A%2F%2Ft.co%2FzgTxwhdbsM%3Famp%3D1&if=false&ts=1591730720369&sw=1600&sh=1200&v=2.9.18&r=stable&ec=0&o=30&fbp=fb.1.1591730720368.205095640&it=1591730720122&coo=false&rqm=GET
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f158:82:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:20 GMT, Tue, 09 Jun 2020 19:25:20 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
alt-svc
h3-27=":443"; ma=3600
content-length
44
expires
Tue, 09 Jun 2020 19:25:20 GMT
/
www.facebook.com/tr/ 		44 B
101 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.facebook.com/tr/?id=1490749274588634&ev=Microdata&dl=https%3A%2F%2Fwww.renaissancecapital.com%2FIPO-Center%2FNews%2F68733%2FPreclinical-vaccine-biotech-Vaxcyte-sets-terms-for-%24210-million-IPO&rl=https%3A%2F%2Ft.co%2FzgTxwhdbsM%3Famp%3D1&if=false&ts=1591730720872&cd[DataLayer]=%5B%5D&cd[Meta]=%7B%22title%22%3A%22Preclinical%20vaccine%20biotech%20Vaxcyte%20sets%20terms%20for%20%24210%20million%20IPO%20-%20Renaissance%20Capital%22%2C%22meta%3Adescription%22%3A%22Vaxcyte%2C%20a%20preclinical%20biotech%20developing%20pneumococcal%20vaccines%2C%20announced%20terms%20for%20its%20IPO%20on%20Monday.%20-%20Renaissance%20Capital%22%7D&cd[OpenGraph]=%7B%22og%3Asite_name%22%3A%22Renaissance%20Capital%22%2C%22og%3Atitle%22%3A%22Preclinical%20vaccine%20biotech%20Vaxcyte%20sets%20terms%20for%20%24210%20million%20IPO%22%2C%22og%3Adescription%22%3A%22Vaxcyte%2C%20a%20preclinical%20biotech%20developing%20pneumococcal%20vaccines%2C%20announced%20terms%20for%20its%20IPO%20on%20Monday.%22%2C%22og%3Aurl%22%3A%22https%3A%2F%2Fwww.renaissancecapital.com%2FIPO-Center%2FNews%2F68733%2FPreclinical-vaccine-biotech-Vaxcyte-sets-terms-for-%24210-million-IPO%22%2C%22og%3Atype%22%3A%22article%22%2C%22og%3Aimage%22%3A%5B%22https%3A%2F%2Fwww.renaissancecapital.com%2Flogos%2FPCVX_logo_fb.jpg%22%2C%22https%3A%2F%2Fwww.renaissancecapital.com%2Fimages%2FRenaissanceCapital_fb.png%22%5D%7D&cd[Schema.org]=%5B%5D&cd[JSON-LD]=%5B%5D&sw=1600&sh=1200&v=2.9.18&r=stable&ec=1&o=30&fbp=fb.1.1591730720368.205095640&it=1591730720122&coo=false&es=automatic&tm=3&rqm=GET
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f158:82:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Referer
https://www.renaissancecapital.com/IPO-Center/News/68733/Preclinical-vaccine-biotech-Vaxcyte-sets-terms-for-$210-million-IPO
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 19:25:20 GMT, Tue, 09 Jun 2020 19:25:20 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
alt-svc
h3-27=":443"; ma=3600
content-length
44
expires
Tue, 09 Jun 2020 19:25:20 GMT

Verdicts & Comments Add Verdict or Comment

79 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| onformdata object| onpointerrawupdate object| dataLayer function| postscribe object| google_tag_manager object| google_tag_data string| GoogleAnalyticsObject function| ga function| twq object| gaplugins object| gaGlobal object| gaData function| gtag object| twttr function| GooglemKTybQhCsO function| google_trackConversion object| GooglebQhCsO function| $ function| jQuery string| _linkedin_data_partner_id function| lintrk boolean| _already_called_lintrk object| angular object| OptiMonkRegistry object| OptiMonk function| ns function| geturi function| publicsitedomainname function| formatdate function| dateComparator function| textComparator function| pctChangeComparator function| dealSizeComparator function| ttlReturnComparator function| sharesComparator function| utcdateparse function| thisweekmonday function| apppath function| getPriceRange function| getSharesToOffer function| inMillions function| formatdateyyyy function| formatmmddyyyy function| numberWithCommas function| addAgGridBorder function| articleModel function| linktoprofile object| app string| adroll_adv_id string| adroll_pix_id function| onRecartMessengerPluginLoaded undefined| _gsDefine undefined| _gsQueue undefined| GreenSockGlobals object| intlTelInputGlobals function| omFlatpickr object| hu function| OMCustomJS_2 boolean| OM_FA_INIT boolean| __adroll_loaded string| adroll_sid object| __adroll boolean| adroll_optout object| adroll_ext_network object| adroll_callbacks function| adroll_tpc_callback number| t function| __cmp object| __adroll_consent boolean| __adroll_consent_is_gdpr object| __adroll_consent_data string| __adroll_consent_user_country string| __adroll_consent_adv_country object| adroll_exp_list object| $jscomp string| BANNER_VERSION object| __adroll_consent_banner function| fbq function| _fbq

0 Cookies

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Content-Security-Policy referrer always;
Strict-Transport-Security max-age=0
X-Xss-Protection 0

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

analytics.twitter.com
cdn-content.optimonk.com
cdn-static.optimonk.com
cdnjs.cloudflare.com
connect.facebook.net
d.adroll.com
d.adroll.mgr.consensu.org
data.renaissancecapital.com
editor-upload-cdn.optimonk.com
fonts.googleapis.com
fonts.gstatic.com
front.optimonk.com
googleads.g.doubleclick.net
maxcdn.bootstrapcdn.com
px.ads.linkedin.com
s.adroll.com
snap.licdn.com
static.ads-twitter.com
stats.g.doubleclick.net
t.co
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googleadservices.com
www.googletagmanager.com
www.linkedin.com
www.renaissancecapital.com
zpr.io
104.244.42.195
104.244.42.5
151.101.112.157
173.251.78.140
18.214.66.67
184.51.8.183
195.181.175.46
195.181.175.49
195.181.175.51
2001:4de0:ac19::1:b:2a
216.58.207.34
2606:4700::6810:85e5
2620:1ec:21::14
2a00:1450:4001:801::200a
2a00:1450:4001:809::2002
2a00:1450:4001:809::2008
2a00:1450:4001:814::2003
2a00:1450:4001:815::2004
2a00:1450:4001:81b::200e
2a00:1450:4001:825::2003
2a00:1450:400c:c00::9b
2a02:26f0:10c:382::25ea
2a03:2880:f058:f:face:b00c:0:3
2a03:2880:f158:82:face:b00c:0:25de
2a05:f500:11:101::b93f:9005
46.101.154.21
99.81.9.236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